A contributing role of Angiotensin II (Ang-II) in ED, related to RA, has been suggested since Ang-II enhances superoxide anion production by stimulation of NADP(H) oxidase, and the treatment with angiotensin II receptor blockers (ARBs) led to a reduction of superoxide anions and the improvement of endothelial function [44,45]. Here, AGT is linked to rheumatoid arthritis.